Sanofi to buy Provention Bio for $25 per share in deal worth $2.9 billion
French pharmaceutical group Sanofi said Monday that it will buy Provention Bio, Inc., a U.S.-based biopharmaceutical company focused on autoimmune diseases, for $25 per share in cash, in a deal with an equity value of $2.9 billion.
The deal will allow Sanofi to add to its portfolio, TZIELD, which was approved in the U.S. last year as the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes . Provention announced late last year a deal with Sanofi to co-promote the treatment in the U.S..
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
William Shatner shares his morbid reason for doing a bio-doc'My time is limited, so that’s very much a factor. I’ve got grandchildren. This documentary is a way of reaching out after I die,' the actor said in a recent interview.
Weiterlesen »
Researchers test creating air filters made from bio-degradable cornA team of researchers at Washington State University is trying to purify the air by creating filters made of bio-degradable corn.
Weiterlesen »
French protests push for withdrawal of Macron’s pension planOpponents of French President Emmanuel Macron’s plan to raise the retirement age from 62 to 64 staged a new round of protests Saturday to push the government to withdraw the unpopular plan.
Weiterlesen »
French protests push for withdrawal of Macron's pension planPARIS (AP) — Opponents of French President Emmanuel Macron’s plan to raise the retirement age from 62 to 64 staged a new round of protests Saturday to push the government to withdraw the unpopular plan.
Weiterlesen »
K-Way to Supply French Team for America’s Cup Sailing RaceK-Way which has become synonymous with its signature packable windbreaker, will provide technical regatta and leisurewear apparel for the Orient Express Team at the sailing race in Barcelona in 2024.
Weiterlesen »